Going Abroad? International Registrations for Medical Devices

by | Feb 23, 2018 | Medical Devices, Uncategorized

Posted By: Stephanie Bouzounis, Senior Communications Specialist

Medical device manufacturers have much to think about when it comes to registering a product internationally. Different regions and countries have different standards for registration. With the impending divorce of the U.K. from the European Union, there are even more considerations to be made. For comparison, the Food and Drug Administration (FDA) states that entities involved in the production and distribution of medical devices in the United States, even those imported and exported, are required to annually register with the FDA.

Here is an overview for the things to look for when registering a medical device globally:

North America

“Registering a medical device in Canada should be a speedy process. Canada is similar to the United States in terms of the process, tests, and protocols it uses. Additionally, there is a mutual recognition between Canada and the United States regarding inspections,” said Ed Rozynski, Senior International Advisor for the Medical Device Manufacturers Association (MDMA), in correspondence with EMMA International. Registering a medical device in Mexico is not generally a difficult process. A Class I, Class II, or Class III medical device manufacturer approved by the FDA for sale in the United States can apply for registration in Mexico without submitting the extensive technical data paperwork required. However, according to Rozynski, it is more challenging to get reimbursement for a product in Mexico.


On Tuesday, February 20th, MDMA’s International Working Group hosted a conference call with Phil Brown, Director of Regulatory Affairs for the Association of British Healthcare Industries (ABHI). The latest European regulation and directives were discussed. One of the major updates is that certifications issued per the medical device directive now have a shelf life of four years. Any changes to devices now must go through a process of reassessment. Additionally, these directives and regulations now strengthen post-market surveillance, and reinforcement of rules on clinical evidence. The matter of Brexit and medical device registration is still on the table. Brown stated in the MDMA call that there are no new updates regarding these regulatory issues. He did state that the U.K. may seek to strengthen a relationship with the United States as a result, and there is always the possibility the U.K. could vote to stay in the European Union (EU).


Rozynski stated there needs to be a lot of patience on the part of the manufacturer when registering a medical device in Asia. Each country is different. For instance, Japan has the longest process. Registration is straightforward in Korea. Korea is a good place to perform clinical trials not just for use in Korea, but globally. Reimbursement in Asia, however, is becoming a larger issue.

For more information and/or questions on international medical device registrations that were not answered here, please call (248) 987-4497or email info@emmainternational.com.

Interested in more? Check out these blogs on our website:

Emma International

Emma International

More Resources

Pattern Recognition as a Quality Superpower

Pattern Recognition as a Quality Superpower

There are always new ways and reasons to apply pattern recognition to quality improvement. Better ensuring patient outcomes in health care facilities and improving accuracy for medical diagnoses are two such frontiers.
Record Control for a Regulated World

Record Control for a Regulated World

In a regulated industry, the prevailing posture of regulatory representatives, in my experience, has been “Show me proof.” In fact, the philosophy I’ve heard repeated by regulators is “If it wasn’t documented, it didn’t happen.”
EU MDR SSCP’s: The Importance of Readability

EU MDR SSCP’s: The Importance of Readability

Among many of the new requirements that EU MDR has introduced, the Summary of Safety and Clinical Performance (SSCP) is certainly one of the more confusing ones for many firms. SSCP’s are required for implantable and Class III devices under EU MDR and is intended to be a public document summarizing important safety and clinical performance information about the device.

Ready to learn more about working with us?

Pin It on Pinterest

Share This